Iovance Biotherapeutics Inc. buy Barclays PLC
Start price
14.04.25
/
50%
€3.00
Target price
14.04.26
€4.39
Performance (%)
-30.81%
Price
19.01.26
€2.08
Summary
This prediction is currently active. Massive losses of -30.81% have been the result for the BUY prediction by Barclays_PLC. This prediction currently runs until 14.04.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | 1.047% | 1.047% |
| iShares Core DAX® | -1.875% | 2.861% |
| iShares Nasdaq 100 | -2.177% | 0.048% |
| iShares Nikkei 225® | -0.867% | 6.987% |
| iShares S&P 500 | -1.253% | 1.248% |
Comments by Barclays_PLC for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Barclays PLC from $22.00 to $5.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€2.44
24.12.25
24.12.25
€8.47
24.12.26
24.12.26
-15.01%
19.01.26
19.01.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
12.05.25
12.05.25
€3.56
12.05.26
12.05.26
27.00%
19.01.26
19.01.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€15.05
29.02.24
29.02.24
€20.28
28.02.25
28.02.25
-73.24%
01.03.25
01.03.25